Member of 
Previously affiliated with Allianz
With more than €90 million invested in 15 companies in Europe and five IPOs, Idinvest Partners is a major provider of financing for growth companies in the healthcare sector.
Building on its recent partnership with Kurma Biofund for the management of existing portfolio holdings and new investments, Idinvest partners' strategy is focused on new drugs, therapeutic processes and diagnostics as well as new markets in biotechnology, health and healthcare services and nutrition, with priority given to investments providing for a rapid rotation rate (exit horizon of 3-5 years).
